Abstract
Monitoring blood beta-hydroxybutyrate is essential in the diagnosis and management of pediatric diabetic-ketoacidosis. Point-of-care capillary beta-hydroxybutyrate testing requires further evaluation in monitoring ketonemia. Study design: Prospective observational analytical study. Setting: Division of Pediatric Critical Care, Department of Pediatrics, JIPMER in collaboration with the Department of Biochemistry, JIPMER from July 2015 to March 2017. Participants: 48 children
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
